Role of Acute Graft-Versus-Host Disease in the Risk of Bacteremia and Invasive Fungal Disease after Allogeneic Hemopoietic Stem Cell Transplantation in Children. Results from a Single-Center Observational Study

被引:21
作者
Castagnola, Elio [1 ]
Bagnasco, Francesca [2 ]
Bandettini, Roberto [3 ]
Caviglia, Ilaria [1 ]
Morreale, Giuseppe [4 ]
Lanino, Edoardo [4 ]
Giardino, Stefano [4 ]
Moroni, Cristina [1 ]
Haupt, Riccardo [2 ]
Faraci, Maura [4 ]
机构
[1] Ist Giannina Gaslini, Infect Dis Unit, I-16147 Genoa, Italy
[2] Ist Giannina Gaslini, Epidemiol Biostat & Comm Unit, I-16147 Genoa, Italy
[3] Ist Giannina Gaslini, Lab Anal, I-16147 Genoa, Italy
[4] Ist Giannina Gaslini, Dept Haematol Oncol, HSCT Unit, I-16147 Genoa, Italy
关键词
Acute graft-versus-host disease; Bacteremia; Invasive fungal disease; Allogeneic hemopoietic stem; cell transplantation; Children; INFECTIOUS COMPLICATIONS; EPIDEMIOLOGY; BLOOD; NEUTROPENIA; RECIPIENTS; MYCOSES; 1ST;
D O I
10.1016/j.bbmt.2014.03.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data on epidemiology of severe infectious complications, ie, bacteremia or invasive fungal disease (IFD), in children with acute graft-versus-host disease (aGVHD) after allogeneic hemopoietic stem cell transplantation (HSCT) are scarce. In a retrospective, single-center study, we analyzed the risk (hazard ratio [HR]) and the rate (episodes/1000 patients days at risk) of bacteremias and IFD in children receiving allogeneic HSCT, according to the type of donor (matched related [MRD] or alternative [AD]) and presence and grade of aGVHD. From 2000 to 2009, 198 children receiving 217 allogeneic HSCT developed 134 severe infectious episodes (103 bacteremias and 31 IFD). The type of donor (AD versus MRD) was the most important risk factor for the severe infections (P =.0052). In separate multivariable analysis for bacteremia and IFD, children receiving an AD HSCT had increased HR and rate of bacteremia compared with those receiving a MRD transplantation (P =.0171 and P =.0001, respectively), whereas the HR and the rate of IFD were significantly influenced by the grade of aGVHD (P =.0002 and P <.0001, respectively). Finally, infectious episodes occurred late after HSCT, especially in presence of severe aGVHD, and bacteremias were 3 to 6 times more frequent than IFD. These data may be important to design management strategies of infections in pediatric allogeneic HSCT. (C) 2014 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1068 / 1073
页数:6
相关论文
共 50 条
  • [21] Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Servais, Sophie
    Beguin, Yves
    Delens, Loic
    Ehx, Gregory
    Fransolet, Gilles
    Hannon, Muriel
    Willems, Evelyne
    Humblet-Baron, Stephanie
    Belle, Ludovic
    Baron, Frederic
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) : 957 - 972
  • [22] Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics
    Gray, Ashley N.
    Defilipp, Zachariah
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (08): : 484 - 491
  • [23] Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia
    Kato, Motohiro
    Kurata, Mio
    Kanda, Junya
    Kato, Koji
    Tomizawa, Daisuke
    Kudo, Kazuko
    Yoshida, Nao
    Watanabe, Kenichiro
    Shimada, Hiroyuki
    Inagaki, Jiro
    Koh, Katsuyoshi
    Goto, Hiroaki
    Kato, Keisuke
    Cho, Yuko
    Yuza, Yuki
    Ogawa, Atsushi
    Okada, Keiko
    Inoue, Masami
    Hashii, Yoshiko
    Teshima, Takanori
    Murata, Makoto
    Atsuta, Yoshiko
    BONE MARROW TRANSPLANTATION, 2019, 54 (01) : 68 - 75
  • [24] Graft-Versus-Host Disease of the Lung after Allogeneic Hematopoietic Stem Cell Transplantation - A Report of Two Cases
    Roh, Ji Hyeon
    Han, Joungho
    Yoo, Keon-Hee
    Ahn, Kang-Mo
    Kim, Jihye
    KOREAN JOURNAL OF PATHOLOGY, 2009, 43 (04) : 378 - 381
  • [25] Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
    Yang, Jun
    Cheuk, Daniel Ka Leung
    Ha, Shau Yin
    Chiang, Alan Kwok Shing
    Lee, Tsz Leung
    Ho, Marco Hok Kung
    Chan, Godfrey Chi Fung
    PEDIATRIC TRANSPLANTATION, 2012, 16 (07) : 771 - 778
  • [26] Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
    Margolis, Elisa B.
    Alfaro, Gabriela Maron
    Sun, Yilun
    Dallas, Ronald H.
    Allison, Kim J.
    Ferrolino, Jose
    Ross, Hailey S.
    Davis, Amy E.
    Jia, Qidong
    Turner, Paige
    Mackay, Victoria
    Morin, Cara E.
    Triplett, Brandon M.
    Klein, Eileen J.
    Englund, Janet A.
    Tang, Li
    Hayden, Randall T.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (05) : 627 - 636
  • [27] Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease
    Yanez, L.
    Insunza, A.
    Ibarrondo, P.
    de Miguel, C.
    Bermudez, A.
    Colorado, M.
    Lopez-Duarte, M.
    Richard, C.
    Conde, E.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (05) : 761 - 767
  • [28] Angiogenic Factors Are Associated with Development of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    聂第敏
    吴秋玲
    朱夏夏
    张然
    郑鹏
    方俊
    游泳
    仲照东
    夏凌辉
    洪梅
    Current Medical Science, 2015, (05) : 694 - 699
  • [29] Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation
    Weber, D.
    Meedt, Elisabeth
    Poeck, Hendrik
    Thiele-Orberg, Eric
    Hiergeist, Andreas
    Gessner, Andre
    Holler, Ernst
    VISCERAL MEDICINE, 2024, 40 (04) : 210 - 216
  • [30] Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Grau, Santiago
    Camara, Rafael
    Jurado, Manuel
    Sanz, Jaime
    Aragon, Belen
    Gozalbo, Irmina
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (04) : 627 - 636